XBiotech Inc. (XBIT)
After hours:
XBiotech Inc.
5217 Winnebago Lane
Austin, TX 78744
United States
512 386 2900
https://www.xbiotech.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 82
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Mr. John Simard | Founder, President, CEO & Chairman | 4.67M | N/A | 1962 |
| Dr. Sushma Shivaswamy Ph.D. | Chief Scientific Officer | 381.24k | N/A | 1978 |
| Ms. Angela Hu | Director of Finance, Principal Financial & Accounting Officer and Financial Controller | N/A | N/A | 1984 |
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Corporate governance
XBiotech Inc.’s ISS governance QualityScore as of 1 April 2024 is 8. The pillar scores are Audit: 9; Board: 7; Shareholder rights: 5; Compensation: 9.
